Bayesian Capital Management’s National Instruments Corp NATI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-31,006
Closed -$1.63M 1141
2023
Q1
$1.63M Buy
+31,006
New +$1.55M 0.2% 146
2022
Q4
Sell
-20,100
Closed -$759K 1094
2022
Q3
$759K Buy
+20,100
New +$760K 0.15% 183
2022
Q2
Sell
-15,600
Closed -$633K 1168
2022
Q1
$633K Buy
+15,600
New +$630K 0.09% 315
2020
Q3
Sell
-11,118
Closed -$430K 737
2020
Q2
$430K Buy
11,118
+3,418
+44% +$129K 0.09% 272
2020
Q1
$255K Buy
+7,700
New +$308K 0.06% 517
2019
Q2
Sell
-10,843
Closed -$481K 714
2019
Q1
$481K Sell
10,843
-40,200
-79% -$1.82M 0.09% 299
2018
Q4
$2.32M Buy
+51,043
New +$2.38M 0.47% 38
2018
Q2
Sell
-9,122
Closed -$461K 773
2018
Q1
$461K Buy
+9,122
New +$444K 0.12% 285

Other funds holding NATI

Bayesian Capital Management's NATI Position: Q2 2023 in Review

Bayesian Capital Management sold out of National Instruments Corp (NATI) in Q2 2023, closing a stake of 31,006 shares — an estimated $1.63M sold.

Bayesian Capital Management first reported a position in NATI in Q1 2018 and held it in 8 quarters. The position peaked at $2.32M in Q4 2018. 355 funds tracked by Wall St. Rank hold NATI as of Q2 2023.

  • Bayesian Capital Management reported no remaining National Instruments Corp position as of Q2 2023 after selling out during the quarter.
  • Bayesian Capital Management sold 31,006 National Instruments Corp shares in Q2 2023, an estimated $1.63M.
  • Bayesian Capital Management first reported a position in National Instruments Corp in Q1 2018 and held it in 8 quarters.
  • Bayesian Capital Management's National Instruments Corp position peaked at $2.32M in Q4 2018.
  • 355 funds tracked by Wall St. Rank held National Instruments Corp as of Q2 2023.

Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.